Zota Health Care acquires equity shares in Curexis Ventures Private Limited via subscription to right issue
Zota Health Care Limited informed the National Stock Exchange of the acquisition of 10,00,000 (10 lakh) equity shares in M/s Curexis Ventures Private Limited, its wholly-owned subsidiary, effected by way of subscription to a right issue. The transaction was disclosed via NSE corporate action filing on 22 June 2026. The consideration amount and detailed terms of the right issue subscription have not been disclosed in the public announcement. As a wholly-owned subsidiary transaction, the deal likely falls within related-party frameworks but may benefit from exemptions under the SEBI LODR Regulations if the subsidiary is not a material unlisted subsidiary.
Why it mattersAcquisition of shares in a wholly-owned subsidiary via right-issue subscription is a capital-infusion mechanism to fund subsidiary operations; review whether this triggers any preferential allotment rules or regulatory disclosure obligations under SEBI (ICDR) Regulations if the parent is listed.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Corporate Action Filing (NSE Archives) · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026